Jumpstart Foundry’s Top-of-Mind: Remote Patient Monitoring

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

In 2018, cliexa was selected as one of Jumpstart Foundry’s portfolio companies. Jumpstart recognizes the value of recent healthcare industry trends including “Remote Patient Monitoring” and “Telehealth.” In their recent article, JSF featured cliexa in their discussion of these recent technological trends in healthcare.

One of the key challenges in healthcare that we are solving is being able to render results interpretable to patients and providers, while creating efficient, streamlined communication and workflow. cliexa’s Remote Monitoring platforms assist providers in making more informed decisions about treatment plans and enable them to respond more quickly to new data so their patients will have fewer complications or side effects. cliexa suite of products enables providers to deliver value-based care which translates to significant cost savings.

With clinically validated scoring models, our platform provides clinicians multiple reference points with correlations to identify the accuracy of patient reported data which will result in better patient and clinician experience and enables more responsive and preventive treatments.

Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient-reported outcomes enable providers to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects.

Click here to learn more about cliexa’s Digital Solutions for Healthcare.

More To Explore

Blog

Telehealth is a Two-Way Street

Clinics and hospitals have substantially reduced in-person visits to reduce potential COVID-19 exposure, the result? Telehealth solutions have become near-essential and their adoption rapidly accelerated.